Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 8, 2013, Pages 692-699

  Li, Chao ^a   Bai, Yuehong ^a   Liu, Hua ^a   Zuo, Xuemei ^b   Yao, Haichang ^a   Xu, Yiming ^a   Cao, Manlin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Changning Center Hospital   (China)

Author keywords

adult dermis; fetal dermis; fibroblasts; keloid; microrna

Indexed keywords

EID: 84880939760     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt057     Document Type: Article

References (47)

1. Uitto J, Perejda AJ, Abergel RP, Chu ML and Ramirez F. Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci USA 1985, 82: 5935-5939.
2. Abergel RP, Pizzurro D, Meeker CA, Lask G, Matsuoka LY, Minor RR and Chu ML, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985, 84: 384-390.
3. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME and Laug WE. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 1996, 106: 1007-1011.
4. Diegelmann RF, Cohen IK and McCoy BJ. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J Cell Physiol 1979, 98: 341-346.
5. Babu M, Diegelmann R and Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989, 9: 1642-1650.
6. Oliver N, Babu M and Diegelmann R. Fibronectin gene transcription is enhanced in abnormal wound healing. J Invest Dermatol 1992, 99: 579-586.
7. Alaish SM, Yager DR, Diegelmann RF and Cohen IK. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 1995, 30: 949-952.
8. Meyer LJ, Russell SB, Russell JD, Trupin JS, Egbert BM, Shuster S and Stern R. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol 2000, 114: 953-959.
9. Luo S, Benathan M, Raffoul W, Panizzon RG and Egloff DV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001, 107: 87-96.
10. Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA and Bayat A. Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol 2011, 164: 83-96.
11. Niessen FB, Spauwen PH, Schalkwijk J and Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999, 104: 1435-1458.
12. Al-Attar A, Mess S, Thomassen JM, Kauffman CL and Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006, 117: 286.
13. Seifert O and Mrowietz U. Keloid scarring: bench and bedside. Arch Dermatol Res 2009, 301: 259-272.
14. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6: 259-269.
15. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao Wand, Cui Q. An analysis of human microRNA and disease associations. PLoS ONE 2008, 3: e3420.
16. Chau BN and Brenner DA. What goes up must come down: the emerging role of microrna in fibrosis. Hepatology 2011, 53: 4-6.
17. Jiang X, Tsitsiou E, Herrick SE and Lindsay MA. MicroRNAs and the regulation of fibrosis. FEBS J 2010, 277: 2015-2021.
18. Brown BD and Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 2009, 10: 578-585.
19. Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS and Hill JA, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008, 105: 13027-13032.
20. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S and Janssen J, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53: 209-218.
21. Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K and Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun 2010, 391: 316-321.
22. Maurer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M and Kowal-Bielecka O, et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 2010, 62: 1733-1743.
23. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M and Galuppo P, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456: 980-984.
24. Thum T, Chau N, Bhat B, Gupta SK, Linsley PS, Bauersachs J and Engelhardt S. Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. J Clin Invest 2011, 121: 461-462.
25. Arakawa M, Hatamochi A, Takeda K and Ueki H. Increased collagen synthesis accompanying elevated m-RNA levels in cultured Werner's syndrome fibroblasts. J Invest Dermatol 1990, 94: 187-190.
26. Dyrskjot L, Zieger K, Kruhoffer M, Thykjaer T, Jensen JL, Primdahl H and Aziz N, et al. A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 2005, 11: 4029-4036.
27. Saeed A, Sharov V, White J, Li J, Liang W, Bhagabati N and Braisted J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34: 374.
28. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D and Sweet-Cordero A, et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435: 834-838.
29. Ala-Kokko L, Rintala A and Savolainen ER. Collagen gene expression in keloids: analysis of collagen metabolism and type I. III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 1987, 89: 238-244.
30. Yuan H, Kaneko T and Matsuo M. Increased susceptibility of late passage human diploid fibroblasts to oxidative stress. Exp Gerontol 1996, 31: 465-474.
31. Hirth A, Skapenko A, Kinne RW, Emmrich F, Schulze-Koops H and Sack U. Cytokine mRNA and protein expression in primary-culture and repeatedpassage synovial fibroblasts from patients with rheumatoid arthritis. Arthritis Res 2002, 4: 117.
32. Baek D, Villén J, Shin C, Camargo FD, Gygi SP and Bartel DP. The impact of microRNAs on protein output. Nature 2008, 455: 64-71.
33. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R and Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455: 58-63.
34. Kashiyama K, Mitsutake N, Matsuse M, Ogi T, Saenko VA, Ujifuku K and Utani A, et al. miR-196a Downregulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol 2012, 132: 1597-1604.
35. Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, Larsson C and Lui WO. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 2010, 130: 2062-2070.
36. Russell SB, Russell JD, Trupin KM, Gayden AE, Opalenik SR, Nanney LB and Broquist AH, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 2010, 130: 2489-2496.
37. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A and Liang S, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006, 103: 9136-9141.
38. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE and Iorio MV, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353: 1793-1801.
39. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA and Jones PA. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9: 435-443.
40. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T and Hammond SM. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 2006, 20: 2202-2207.
41. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W and Nikitin AY. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007, 67: 8433-8438.
42. Zhu H, Li Y, Qu S, Luo H, Zhou Y, Wang Y and Zhao H, et al. MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol 2012, 32: 514-522.
43. Smith JC, Boone BE, Opalenik SR,Williams SM and Russell SB. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 2008, 128: 1298-1310.
44. Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C and Wan J, et al. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res 2011, 17: 6802-6811.
45. Ukai T, Sato M, Akutsu H, Umezawa A and Mochida J. MicroRNA-199a-3p, microRNA-193b, and microRNA-320c are correlated to aging and regulate human cartilage metabolism. J Orthop Res 2012, 30: 1915-1922.
46. Ritprajak P, Hashiguchi M and Azuma M. Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. Mol Ther 2008, 16: 1323-1330.
47. Bak RO and Mikkelsen JG. Regulation of cytokines by small RNAs during skin inflammation. J Biomed Sci 2010, 17: 53.